Relay Therapeutics Inc. Common Stock vs WisdomTree Inc. Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B), while WisdomTree Inc. Common Stock trades at $22.83 (market cap $3.54B). The key difference: Relay Therapeutics Inc. Common Stock and WisdomTree Inc. Common Stock are close in size by market cap, and WisdomTree Inc. Common Stock pays a 0.51% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and WisdomTree Inc. Common Stock for 0 Days on average.
| RLAY | WT | |
|---|---|---|
Market Cap | $3.94B | $3.54B |
Volume | 3,432,928 | 1,948,608 |
Sector | Health | Financials |
52-Week High | $20.75 | $25.04 |
52-Week Low | $6.03 | $10.73 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.06B | $4.29B |
Dividend Yield | — | 0.51% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →WisdomTree provides exchange-traded products, model portfolios, and digital-asset-related products and services. Its digital offerings include tokenized funds, an institutional platform, and a blockchain-native wallet.
Read more on WT →